| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | GPLD1 PDE8A MTMR8 LHPP PPM1G PIKFYVE PTPN3 FICD PTPN7 FIG4 PDE7B | 4.23e-05 | 386 | 129 | 11 | GO:0042578 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 1.39e-04 | 16 | 129 | 3 | GO:0106018 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 5.46e-04 | 25 | 129 | 3 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 5.46e-04 | 25 | 129 | 3 | GO:0055056 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity | 6.11e-04 | 6 | 129 | 2 | GO:0043813 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 6.88e-04 | 27 | 129 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 6.88e-04 | 27 | 129 | 3 | GO:0034593 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 8.51e-04 | 29 | 129 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | prolactin receptor binding | 8.51e-04 | 7 | 129 | 2 | GO:0005148 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 9.41e-04 | 30 | 129 | 3 | GO:0052866 | |
| GeneOntologyBiologicalProcess | protein localization to M-band | 3.94e-05 | 2 | 130 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | positive regulation of mitotic cell cycle spindle assembly checkpoint | 5.16e-05 | 12 | 130 | 3 | GO:0090267 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid hormone biosynthetic process | 6.68e-05 | 13 | 130 | 3 | GO:0090031 | |
| GeneOntologyBiologicalProcess | positive regulation of spindle checkpoint | 6.68e-05 | 13 | 130 | 3 | GO:0090232 | |
| GeneOntologyBiologicalProcess | dephosphorylation | 7.13e-05 | 347 | 130 | 10 | GO:0016311 | |
| Domain | ZU5 | 2.62e-05 | 9 | 129 | 3 | SM00218 | |
| Domain | ZU5 | 3.73e-05 | 10 | 129 | 3 | PS51145 | |
| Domain | ZU5 | 6.77e-05 | 12 | 129 | 3 | PF00791 | |
| Domain | ZU5_dom | 6.77e-05 | 12 | 129 | 3 | IPR000906 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 12527750 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | GALNTL6 MYH9 ANK1 RNF112 PCDHB12 OBSCN LAMB3 PTGS1 KMT2C TRMT6 DROSHA TBK1 PRKDC CHTOP PCMT1 | 1.60e-07 | 736 | 133 | 15 | 29676528 |
| Pubmed | MAP2 DYNC2H1 CUL7 SNAP47 RBM39 PPM1G KMT2C KLHL12 PRKDC ECE2 | 4.97e-07 | 322 | 133 | 10 | 26514267 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPR MYH9 CAD CALML3 MC1R LAMB3 GCDH ZYG11B PHGDH ISG15 PRKDC FBXO21 PCMT1 | 1.32e-06 | 647 | 133 | 13 | 26618866 |
| Pubmed | MTA2 MYH9 CAD GCDH RBM39 PHGDH MYEF2 PPM1G NCOR2 DNAJC10 PRKDC FBXO21 CHTOP | 1.51e-06 | 655 | 133 | 13 | 35819319 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MTA2 TPR MYH9 CAD TAF1C SSRP1 RBM39 PHGDH MYEF2 ACSL1 NCOR2 FBXL18 DKC1 DDX60L PRKDC PYCR3 CHTOP PCMT1 | 4.28e-06 | 1353 | 133 | 18 | 29467282 |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 6.36e-06 | 180 | 133 | 7 | 30110629 | |
| Pubmed | MTA2 MYH9 CAD DYNC2H1 SSRP1 KIFC2 PHGDH PPM1G NCOR2 FIG4 CACNA1G SLC25A29 GOLGA5 | 6.93e-06 | 754 | 133 | 13 | 35906200 | |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 7.25e-06 | 258 | 133 | 8 | 21081666 | |
| Pubmed | 8.82e-06 | 11 | 133 | 3 | 18406329 | ||
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 9.25e-06 | 73 | 133 | 5 | 32347575 | |
| Pubmed | MTA2 PI4K2B CAD DDX60 GCDH SSRP1 SNAP47 RBM39 PHGDH PPM1G DNAJC10 GID4 SIPA1L1 TMEM209 DKC1 DDX60L PRKDC CHTOP | 1.00e-05 | 1440 | 133 | 18 | 30833792 | |
| Pubmed | 1.13e-05 | 130 | 133 | 6 | 12421765 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.35e-05 | 202 | 133 | 7 | 33005030 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 19002483 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 22028657 | ||
| Pubmed | Two new cases of interstitial 7q35q36.1 deletion including CNTNAP2 and KMT2C. | 1.45e-05 | 2 | 133 | 2 | 34582124 | |
| Pubmed | Identification of the interchain disulfide bonds of dimeric human placental lactogen. | 1.45e-05 | 2 | 133 | 2 | 438159 | |
| Pubmed | Obscurin is a ligand for small ankyrin 1 in skeletal muscle. | 1.45e-05 | 2 | 133 | 2 | 12631729 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 26405034 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 14976209 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 19004958 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 19073728 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 4712450 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 33152322 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 17720975 | ||
| Pubmed | Two structurally different genes produce the same secreted human placental lactogen hormone. | 1.45e-05 | 2 | 133 | 2 | 6300056 | |
| Pubmed | Cotranslational sequestration of egg white proteins and placental lactogen inside membrane vesicles. | 1.45e-05 | 2 | 133 | 2 | 6930851 | |
| Pubmed | Importance of innate immunity and collagen binding integrin alpha1beta1 in TNBS-induced colitis. | 1.45e-05 | 2 | 133 | 2 | 12479823 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 6208192 | ||
| Pubmed | Multiple origins of transcription for the human placental lactogen genes. | 1.45e-05 | 2 | 133 | 2 | 6209277 | |
| Pubmed | Roles for a lipid phosphatase in the activation of its opposing lipid kinase. | 1.45e-05 | 2 | 133 | 2 | 32583743 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23708657 | ||
| Pubmed | Distinct fetal Ank-1 and Ank-2 related proteins and mRNAs in normal and nb/nb mice. | 1.45e-05 | 2 | 133 | 2 | 8471772 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 16254333 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 11157743 | ||
| Pubmed | Expression of Ki-67, Bax and p73 in patients with hilar cholangiocarcinoma. | 1.45e-05 | 2 | 133 | 2 | 24934361 | |
| Pubmed | The Ndc80 complex targets Bod1 to human mitotic kinetochores. | 1.45e-05 | 2 | 133 | 2 | 29142109 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 5286363 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 32795325 | ||
| Pubmed | Construction and analysis of recombinant DNA for human chorionic somatomammotropin. | 1.45e-05 | 2 | 133 | 2 | 593368 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 30529400 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 20946978 | ||
| Pubmed | Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A. | 1.63e-05 | 82 | 133 | 5 | 30274258 | |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 1.95e-05 | 85 | 133 | 5 | 16051665 | |
| Pubmed | MYH9 CAD LAMB3 SSRP1 RBM39 PHGDH TBK1 DKC1 PRKDC PYCR3 CHTOP | 2.11e-05 | 601 | 133 | 11 | 33658012 | |
| Pubmed | 2.95e-05 | 16 | 133 | 3 | 18258596 | ||
| Pubmed | 2.95e-05 | 16 | 133 | 3 | 10882104 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MTA2 TPR CAD CUL7 SSRP1 RBM39 PHGDH MYEF2 MYO5C TBK1 DKC1 PRKDC CHTOP PCMT1 | 4.01e-05 | 1024 | 133 | 14 | 24711643 |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 18259191 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 19037259 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 18981471 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 22387044 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 22028665 | ||
| Pubmed | p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. | 4.34e-05 | 3 | 133 | 2 | 14634023 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 35810100 | ||
| Pubmed | Covalent protein modification with ISG15 via a conserved cysteine in the hinge region. | 4.34e-05 | 3 | 133 | 2 | 22693631 | |
| Pubmed | The chloride antiporter CLCN7 is a modifier of lysosome dysfunction in FIG4 and VAC14 mutants. | 4.34e-05 | 3 | 133 | 2 | 37363915 | |
| Pubmed | FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth. | 4.34e-05 | 3 | 133 | 2 | 32187554 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 21177872 | ||
| Pubmed | p73 modulates HIV-1 Tat transcriptional and apoptotic activities in human astrocytes. | 4.34e-05 | 3 | 133 | 2 | 16235026 | |
| Pubmed | Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line. | 4.34e-05 | 3 | 133 | 2 | 18782775 | |
| Pubmed | Pathogenic variants of DYNC2H1, KIAA0556, and PTPN11 associated with hypothalamic hamartoma. | 4.34e-05 | 3 | 133 | 2 | 31197031 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 31428903 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 17010584 | ||
| Pubmed | A novel response element confers p63- and p73-specific activation of the WNT4 promoter. | 4.34e-05 | 3 | 133 | 2 | 16343436 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 19840946 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 16597699 | ||
| Pubmed | Involvement of the p53 and p73 transcription factors in neuroAIDS. | 4.34e-05 | 3 | 133 | 2 | 18719392 | |
| Pubmed | UBE1L causes lung cancer growth suppression by targeting cyclin D1. | 4.34e-05 | 3 | 133 | 2 | 19074853 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 18950639 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 9312053 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 23047693 | ||
| Pubmed | The DNA-PK catalytic subunit regulates Bax-mediated excitotoxic cell death by Ku70 phosphorylation. | 4.34e-05 | 3 | 133 | 2 | 19664609 | |
| Pubmed | The human growth hormone gene locus: structure, evolution, and allelic variations. | 4.34e-05 | 3 | 133 | 2 | 3030680 | |
| Pubmed | Spindle assembly checkpoint robustness requires Tpr-mediated regulation of Mad1/Mad2 proteostasis. | 4.34e-05 | 3 | 133 | 2 | 24344181 | |
| Pubmed | The impact of ISGylation during Mycobacterium tuberculosis infection in mice. | 4.34e-05 | 3 | 133 | 2 | 28087453 | |
| Pubmed | DEC1 coordinates with HDAC8 to differentially regulate TAp73 and ΔNp73 expression. | 4.34e-05 | 3 | 133 | 2 | 24404147 | |
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 4.34e-05 | 3 | 133 | 2 | 33410423 | |
| Pubmed | Cofactors and metabolites as potential stabilizers of mitochondrial acyl-CoA dehydrogenases. | 4.34e-05 | 3 | 133 | 2 | 21968293 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 17556371 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 15531513 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 8674830 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 25918374 | ||
| Pubmed | Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue. | 4.34e-05 | 3 | 133 | 2 | 34289389 | |
| Pubmed | ALPK1 phosphorylates myosin IIA modulating TNF-α trafficking in gout flares. | 4.34e-05 | 3 | 133 | 2 | 27169898 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 22201672 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 29891555 | ||
| Pubmed | 4.44e-05 | 51 | 133 | 4 | 34316707 | ||
| Pubmed | 5.44e-05 | 551 | 133 | 10 | 34728620 | ||
| Pubmed | 5.64e-05 | 106 | 133 | 5 | 19394292 | ||
| Pubmed | MTA2 MYH9 CAD ACADS CALML3 RBM39 PHGDH MYEF2 ISG15 PRKDC CHTOP PCMT1 | 6.34e-05 | 803 | 133 | 12 | 36517590 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | 6.69e-05 | 565 | 133 | 10 | 33567341 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 6.98e-05 | 457 | 133 | 9 | 32344865 | |
| Pubmed | 7.94e-05 | 267 | 133 | 7 | 33417871 | ||
| Pubmed | 8.50e-05 | 469 | 133 | 9 | 37314180 | ||
| Pubmed | The basis for selective E1-E2 interactions in the ISG15 conjugation system. | 8.67e-05 | 4 | 133 | 2 | 18583345 | |
| Pubmed | PINK1/Parkin Influences Cell Cycle by Sequestering TBK1 at Damaged Mitochondria, Inhibiting Mitosis. | 8.67e-05 | 4 | 133 | 2 | 31577952 | |
| Pubmed | Spatiotemporal control of mitosis by the conserved spindle matrix protein Megator. | 8.67e-05 | 4 | 133 | 2 | 19273613 | |
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 29932067 | ||
| GeneFamily | Growth hormone family | 3.16e-04 | 6 | 84 | 2 | 1175 | |
| GeneFamily | Acyl-CoA dehydrogenase family | 1.14e-03 | 11 | 84 | 2 | 974 | |
| GeneFamily | Maestro heat like repeat containing | 1.14e-03 | 11 | 84 | 2 | 636 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 1.86e-06 | 194 | 132 | 7 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | mild-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.99e-06 | 196 | 132 | 7 | ded44b38ea489946e9eedfe752b5a9fde9149c16 | |
| ToppCell | mild-Myeloid-Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.99e-06 | 196 | 132 | 7 | e9f30eb8a3915c3b2af009c832bff9b349b65ae5 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.13e-06 | 198 | 132 | 7 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.28e-06 | 200 | 132 | 7 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-06 | 150 | 132 | 6 | 34774b015adecc2be56a471fda8994e89a6ad93e | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-05 | 168 | 132 | 6 | 32e4d82efaccf336d347e4063253c3635a3ec672 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.14e-05 | 169 | 132 | 6 | 625788d86f0ceebcf2653a251db1f1a9f9746d29 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 175 | 132 | 6 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 175 | 132 | 6 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-05 | 179 | 132 | 6 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-05 | 179 | 132 | 6 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 1.68e-05 | 181 | 132 | 6 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.68e-05 | 181 | 132 | 6 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | mild_COVID-19-Plasmablast|World / disease group, cell group and cell class (v2) | 2.08e-05 | 188 | 132 | 6 | 9a5ba6abdc307402301dae25db2a5f3e0d576417 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.21e-05 | 190 | 132 | 6 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.21e-05 | 190 | 132 | 6 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.21e-05 | 190 | 132 | 6 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.34e-05 | 192 | 132 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.34e-05 | 192 | 132 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.48e-05 | 194 | 132 | 6 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.48e-05 | 194 | 132 | 6 | eb23b171e429165dd26a64377eae7fa2ce25f547 | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.70e-05 | 197 | 132 | 6 | 3b71e523d8a68f131def17233385df371db70db5 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.70e-05 | 197 | 132 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | control-Myeloid-Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.70e-05 | 197 | 132 | 6 | 8819db1550bf14566c6d33d97f7f83419e867ace | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.78e-05 | 198 | 132 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.78e-05 | 198 | 132 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Transverse-T_cell-Tfh|Transverse / Region, Cell class and subclass | 2.86e-05 | 199 | 132 | 6 | cbef8f95edf2e86e16c448a76068d7ed8f6b7748 | |
| ToppCell | Transverse-(1)_T_cell-(16)_Tfh|Transverse / shred on region, Cell_type, and subtype | 2.86e-05 | 199 | 132 | 6 | aa31e26d48066f865ca33251a33a28934c0a7a44 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 2.86e-05 | 199 | 132 | 6 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.94e-05 | 200 | 132 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.94e-05 | 200 | 132 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.97e-05 | 134 | 132 | 5 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 156 | 132 | 5 | d72c2f5f72d269e29033f8728d924e0d4c8772c7 | |
| ToppCell | Basal_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.08e-04 | 158 | 132 | 5 | 51e3ed1b91b010404d66e3e7efdbffc0c815e25b | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-04 | 158 | 132 | 5 | 41cf950983f47a9e55d56041b301006b42853b37 | |
| ToppCell | FLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.12e-04 | 159 | 132 | 5 | 97c8e16a7ac10ebba96daee97f9fb1d4a404f23b | |
| ToppCell | FLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster | 1.12e-04 | 159 | 132 | 5 | fe2a9f79b058e89214256e736f6e266830cdfa28 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 161 | 132 | 5 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 162 | 132 | 5 | 3dc39db0d5f6f3d7bcc312a6bce7aaeb914138d1 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 162 | 132 | 5 | 0a7138266054ea5954649c8b61ef93905d56b068 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 162 | 132 | 5 | 25323785dd33337bcefd05958a4a1a208a9ceb04 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 166 | 132 | 5 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 166 | 132 | 5 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 167 | 132 | 5 | 859dfe0764cb69de27e79e1c1aa65f9d538f79ea | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 167 | 132 | 5 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 167 | 132 | 5 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 168 | 132 | 5 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 169 | 132 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.52e-04 | 170 | 132 | 5 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-04 | 171 | 132 | 5 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 1.57e-04 | 171 | 132 | 5 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.65e-04 | 173 | 132 | 5 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-04 | 177 | 132 | 5 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.84e-04 | 177 | 132 | 5 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.89e-04 | 178 | 132 | 5 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.94e-04 | 179 | 132 | 5 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-04 | 179 | 132 | 5 | e7045e27f0eb88f552b31c04b56d78e5ccd7a36c | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 1.99e-04 | 180 | 132 | 5 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 1.99e-04 | 180 | 132 | 5 | 7f6ce04eeeca53aea9b5bbf5889399b31ff5675b | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.09e-04 | 182 | 132 | 5 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-04 | 182 | 132 | 5 | 6c9a48037fa002bc528875538bdaaf15696d68b6 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.15e-04 | 183 | 132 | 5 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.15e-04 | 183 | 132 | 5 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 184 | 132 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 184 | 132 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 184 | 132 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 185 | 132 | 5 | 6a85399cfdb9b89683c874e7f046957f9a601dc2 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-04 | 185 | 132 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.26e-04 | 185 | 132 | 5 | 3b2da51aec057b462749ae39afb8f253afcf38d5 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 185 | 132 | 5 | 64791056cdbb739136dbef08f4b16e2b5427faad | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-04 | 186 | 132 | 5 | 064b6047215597465bb51a8a1547ef5a226552f9 | |
| ToppCell | mild_COVID-19-Plasmablast|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.32e-04 | 186 | 132 | 5 | a639d2183b85b1be6e6da2b2e112aec5149d5bcd | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 187 | 132 | 5 | bdcef4f3e093c3646b639a189bbe93d6f4c40f3c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 187 | 132 | 5 | 09348f1e8bbbca8dca885461937b9b1dd248b034 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 187 | 132 | 5 | 0f7a42c55997e34a0d20e492e16b03e91e965335 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 187 | 132 | 5 | 064730fa72f8637c3db3fc34d2e363d2b9a38f1d | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.43e-04 | 188 | 132 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-04 | 188 | 132 | 5 | 2c4e791df69a9df29922f9117e5cac7787c129ce | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.43e-04 | 188 | 132 | 5 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-04 | 188 | 132 | 5 | b1ec7c45aedcc3d22cac898c6a3679e7f8b44c77 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-04 | 188 | 132 | 5 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.43e-04 | 188 | 132 | 5 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.49e-04 | 189 | 132 | 5 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-04 | 189 | 132 | 5 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.49e-04 | 189 | 132 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.49e-04 | 189 | 132 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.49e-04 | 189 | 132 | 5 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-04 | 189 | 132 | 5 | cceca3d14dd559bbb2cb4b81ea12c2b62d18ee49 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.55e-04 | 190 | 132 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.55e-04 | 190 | 132 | 5 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.62e-04 | 191 | 132 | 5 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.62e-04 | 191 | 132 | 5 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 191 | 132 | 5 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 191 | 132 | 5 | 45023854f285ac465f23ea1b33c970e14992e709 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 191 | 132 | 5 | 6890a8e4b4530987a5b044614fcd7e00716a4d66 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-04 | 192 | 132 | 5 | d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 192 | 132 | 5 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| Computational | Genes in the cancer module 69. | PI4K2B DDX60 OBSCN LAMB3 LHPP ZMAT4 BHLHE40 MYEF2 PIKFYVE TRMT6 KATNIP EFCC1 PYCR3 | 1.59e-04 | 526 | 82 | 13 | MODULE_69 |
| Computational | Neighborhood of CDK2 | 2.14e-04 | 72 | 82 | 5 | MORF_CDK2 | |
| Drug | orthovanadate | GPLD1 DAND5 PDE8A CALML3 KIFC2 PPM1G PIKFYVE SLC2A10 PTPN3 TBK1 PDE7B SLC2A11 | 8.31e-06 | 435 | 131 | 12 | CID000061672 |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.46e-05 | 190 | 131 | 8 | 5623_UP | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.90e-05 | 197 | 131 | 8 | 5796_UP | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 131 | 8 | 3351_UP | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 131 | 8 | 2751_UP | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; PC3; HT_HG-U133A | 1.90e-05 | 197 | 131 | 8 | 5787_UP | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; HL60; HT_HG-U133A | 1.97e-05 | 198 | 131 | 8 | 2999_DN | |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.04e-05 | 199 | 131 | 8 | 2866_UP | |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; PC3; HT_HG-U133A | 2.12e-05 | 200 | 131 | 8 | 3667_UP | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 2.12e-05 | 200 | 131 | 8 | 251_UP | |
| Drug | Nexus | 2.88e-05 | 152 | 131 | 7 | CID000098527 | |
| Drug | ambutonium | 3.29e-05 | 2 | 131 | 2 | CID000008276 | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; HL60; HT_HG-U133A | 3.54e-05 | 157 | 131 | 7 | 3141_UP | |
| Disease | X-11315 measurement | 1.31e-05 | 11 | 129 | 3 | EFO_0021223 | |
| Disease | endometrial carcinoma (is_marker_for) | 1.46e-05 | 34 | 129 | 4 | DOID:2871 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | MYH9 ANK1 ANK2 DYNC2H1 MTMR8 SH2D3A OBSCN BAX PTGS1 PHGDH SLC2A10 SIPA1L1 EXOC3L1 MMP9 TP73 | 7.36e-05 | 1074 | 129 | 15 | C0006142 |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.15e-04 | 57 | 129 | 4 | DOID:10652 (implicated_via_orthology) | |
| Disease | osteoporosis (biomarker_via_orthology) | 1.18e-04 | 22 | 129 | 3 | DOID:11476 (biomarker_via_orthology) | |
| Disease | testicular cancer (implicated_via_orthology) | 1.88e-04 | 5 | 129 | 2 | DOID:2998 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 1.88e-04 | 5 | 129 | 2 | DOID:0060872 (implicated_via_orthology) | |
| Disease | Tinnitus | 2.73e-04 | 130 | 129 | 5 | HP_0000360 | |
| Disease | Lead Poisoning | 3.93e-04 | 7 | 129 | 2 | C0023176 | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 3.93e-04 | 7 | 129 | 2 | DOID:0060870 (implicated_via_orthology) | |
| Disease | Hereditary spherocytosis | 5.22e-04 | 8 | 129 | 2 | C0037889 | |
| Disease | Parkinson Disease | 5.37e-04 | 85 | 129 | 4 | C0030567 | |
| Disease | Major Depressive Disorder | 7.18e-04 | 243 | 129 | 6 | C1269683 | |
| Disease | ghrelin measurement | 1.30e-03 | 49 | 129 | 3 | EFO_0600001 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.43e-03 | 13 | 129 | 2 | EFO_0800474 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 1.43e-03 | 13 | 129 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | peak expiratory flow | 1.60e-03 | 498 | 129 | 8 | EFO_0009718 | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 1.67e-03 | 14 | 129 | 2 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 1.67e-03 | 14 | 129 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | behavioural inhibitory control measurement | 2.19e-03 | 16 | 129 | 2 | EFO_0008467 | |
| Disease | Huntington's disease (biomarker_via_orthology) | 2.19e-03 | 16 | 129 | 2 | DOID:12858 (biomarker_via_orthology) | |
| Disease | autism spectrum disorder (is_implicated_in) | 2.19e-03 | 16 | 129 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | 2.22e-03 | 525 | 129 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.22e-03 | 525 | 129 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 2.27e-03 | 527 | 129 | 8 | C1458155 | |
| Disease | major depressive disorder (is_implicated_in) | 2.47e-03 | 17 | 129 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | Breast Carcinoma | 2.58e-03 | 538 | 129 | 8 | C0678222 | |
| Disease | Gastric ulcer | 2.77e-03 | 18 | 129 | 2 | C0038358 | |
| Disease | age-related hearing impairment | 3.08e-03 | 324 | 129 | 6 | EFO_0005782 | |
| Disease | glaucoma (is_marker_for) | 3.42e-03 | 20 | 129 | 2 | DOID:1686 (is_marker_for) | |
| Disease | stomach cancer (is_marker_for) | 3.56e-03 | 142 | 129 | 4 | DOID:10534 (is_marker_for) | |
| Disease | Stuttering | 3.65e-03 | 143 | 129 | 4 | HP_0025268 | |
| Disease | quinolinic acid measurement | 3.77e-03 | 21 | 129 | 2 | EFO_0010528 | |
| Disease | bone density, lean body mass | 3.77e-03 | 21 | 129 | 2 | EFO_0003923, EFO_0004995 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 4.02e-03 | 147 | 129 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Testicular Germ Cell Tumor | 4.06e-03 | 73 | 129 | 3 | EFO_1000566 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MGQSLQEGRKQGRLL | 1 | Q96KT6 | |
| TREALSQARGLLQGM | 96 | Q86VI1 | |
| TRGGMSRLFGLEQEI | 176 | Q96LX7 | |
| QTLDMGRIGIASQAL | 266 | P16219 | |
| QSSLGGRVRLMVTGA | 421 | P33121 | |
| GRRFTMGERIGAIKQ | 266 | O14503 | |
| RGEIVNMLEGSGRQS | 1476 | P16157 | |
| QIVLSGRGFMLGSRN | 236 | P58335 | |
| TVSVRRGQGMVLLCG | 131 | Q8IWV2 | |
| MRVAGGRALSRGAEL | 1 | Q0P5N6 | |
| ERLLLTAGVSAGRQM | 176 | Q15782 | |
| ELRLVGGTNRCMGRV | 261 | Q9NR16 | |
| MLVRGRDQGSGSRLG | 1 | Q9H8S5 | |
| ISQLGDLGTRRIQIM | 421 | Q14156 | |
| AMLVEQLRTQGCGGR | 461 | Q9HA90 | |
| SLMGKNVQRELRRGG | 521 | Q96QP1 | |
| GNLGAMLRCVDLSRG | 206 | Q9UF12 | |
| RTGIDLGTTGRLQLM | 346 | Q14498 | |
| QLSQNRGLGGIMVKR | 546 | O94776 | |
| MTSRLRALGGRINNI | 1 | P26045 | |
| GIVCQLRLDRGGMIQ | 321 | P35236 | |
| MAVQGSQRRLLGSLN | 1 | Q01726 | |
| RGNTNMVKLLLDRGG | 276 | Q01484 | |
| QRMVGNLLSLGKREG | 386 | O94952 | |
| AQVTGALRSGRGKML | 611 | P14780 | |
| LQERMQSRVGQRGSG | 346 | Q9Y618 | |
| LQKARQLGMGRLQRG | 66 | Q8N907 | |
| SLGNRRALILLGQMG | 31 | P01566 | |
| GMRSLGLTEEQLRQQ | 351 | Q2VYF4 | |
| GIGGFMVRQRSRTGQ | 1281 | Q8NEZ4 | |
| MALQLSREQGITLRG | 1 | Q13257 | |
| RRTVGILDMGGASLQ | 251 | Q9NQZ7 | |
| MGCDGRVSGLLRRNL | 1 | Q8N468 | |
| TLMENGTLSREGGLR | 581 | Q96EF0 | |
| GTLSREGGLRAQMDQ | 586 | Q96EF0 | |
| DNMRGRTTVGLGLVL | 226 | O95528 | |
| MSGIDNGEGTRLRNV | 641 | Q8TBA6 | |
| GGARAINQAMDRIGL | 411 | O60303 | |
| INQAMDRIGLLGSRQ | 416 | O60303 | |
| STVFMNLRLRGGGTE | 146 | P05161 | |
| IDGNGRTSRLLMNLI | 366 | Q9BVA6 | |
| QMSGRAGRRGQDLMG | 1321 | Q8IY21 | |
| MSGRAGRRGQDLLGN | 1306 | Q5H9U9 | |
| ELGQQIRMNLGGRVD | 71 | Q9NP86 | |
| GIQTLMGRLEDGSRR | 146 | P0DML3 | |
| MGRLEDGSRRTGQIL | 151 | P0DML3 | |
| GAAAQLGGIVRMTLS | 551 | P51798 | |
| RTMVGFQKGTRQLLG | 86 | P0DPD6 | |
| RDRGNVASLIMTGLQ | 1381 | O75051 | |
| MAVRQALGRGLQLGR | 1 | Q9BXM7 | |
| MLGDIRLRGQTGVRA | 26 | Q9NP56 | |
| ANDLVGGLMSDGLRR | 441 | O60658 | |
| SRIGGAQEMERLAQL | 1231 | Q14999 | |
| QMGLLRVISGVLQLG | 336 | P35579 | |
| GGAQRCGMRALQVRT | 221 | Q9H008 | |
| FIILRKRQGSRGAMG | 326 | Q30201 | |
| SRQIAGRIGGGRNMD | 426 | P23219 | |
| VQRGGRQTMTALGID | 241 | P56199 | |
| MENGGAGTLQIRQVL | 1 | Q9Y5F1 | |
| SMGRVRILSGGRQLQ | 2241 | Q96RW7 | |
| TRVLGNGNLMISDVR | 281 | Q2VWP7 | |
| MCARGQVGRGTQLRT | 1 | Q8IVV7 | |
| GGRFEVVSQGRQQML | 4666 | Q5VST9 | |
| MRGQILNLTQALRDG | 421 | Q8TCG2 | |
| IGGSGELQRQRVMEA | 571 | O15350 | |
| LLRDLSGLQGMNGSI | 1106 | Q9Y2I7 | |
| AQAMRGLTLGGQVRT | 526 | Q9HDB9 | |
| GNQMLLRVQRSDAGI | 46 | Q8NCM8 | |
| NLIRGLGGNLNMKSR | 2191 | Q8NCM8 | |
| TGLQGMCVGERRQLI | 441 | Q96AY3 | |
| LGRLLVGVNAGVSMN | 126 | Q9BYW1 | |
| NVRRGLAGATTLGDM | 366 | Q53G59 | |
| QQGLILRRMASQLSG | 126 | A8MY62 | |
| QGGGLSVLRTFRLMR | 826 | O43497 | |
| SRQGEGAVLQRMLGR | 66 | P59020 | |
| IARQARDMLGGNGIS | 381 | Q92947 | |
| ERRGFRVLSMTGVGQ | 61 | P30047 | |
| LLGRLDLGNRTKMGQ | 66 | Q92562 | |
| LRNGLRQSVVQSGML | 111 | Q96IK1 | |
| LLQGFIQDRAGRMGG | 26 | Q07812 | |
| EAINGSGLQMGLQRV | 181 | P09172 | |
| GLRGVNRGMVSTLLR | 146 | Q8N8R3 | |
| RLGQSSMLGEQGARI | 1091 | Q13751 | |
| RELGTVMRSLGQNPT | 31 | P27482 | |
| QGFLGCIRSLRMNGV | 931 | Q9UHC6 | |
| RLRLSGMLDGLVNVG | 276 | Q8IXB1 | |
| GIQTLMGRLEDGSRR | 146 | P0DML2 | |
| MGRLEDGSRRTGQIL | 151 | P0DML2 | |
| LLGVGGQMQELRRVR | 236 | O60832 | |
| LRQTGMGLTALVGRL | 461 | Q9Y694 | |
| AQTINRSLLALGGVM | 656 | Q96AC6 | |
| KGEGRGIAMLNLLRT | 591 | A6NES4 | |
| GLIRTRLLGASMARG | 211 | Q49A17 | |
| GINTLINIMSRLGQD | 941 | Q9NRR4 | |
| LSSGRVQLVVGDGRM | 131 | P22061 | |
| GGGITRDQLSQLLLM | 166 | Q6ZUK4 | |
| RTRGEELTGLMAGSQ | 161 | Q5SQN1 | |
| GSGMRERIGSKGNQI | 511 | Q9P2K5 | |
| GQRLGVLRKAMARGQ | 676 | Q15572 | |
| RTREGAILSGQLMVG | 206 | Q96ME1 | |
| MDGRVNGGLNLSRAI | 386 | O15355 | |
| SVEMTLRRNGLGQLG | 951 | O43166 | |
| NATLRQMAIRGLGNT | 1316 | Q7Z745 | |
| AGRMAGAIAQGLIRA | 16 | Q53H96 | |
| LELAVGQRMRQGSIG | 61 | Q9NP91 | |
| TLRNLQALGTLAGGM | 1181 | Q7RTU9 | |
| GSMNDGRLRLSRQGI | 16 | Q08945 | |
| MSLRGQNLLRGGRAV | 131 | Q9Y3Y2 | |
| ALEGMVRGLRQGGVS | 576 | Q969H4 | |
| KLREGRNIIGLQMGT | 156 | P51911 | |
| GGSRILLRMTLGREV | 16 | Q9BYT8 | |
| LEGRQVMQFGRIDGS | 1501 | Q9NRJ4 | |
| GTVGIFRGNQMRLKR | 71 | Q9C0D3 | |
| GSINLRMRQLNGDGG | 221 | Q9NUR3 | |
| RINASGGLILRMGAI | 141 | Q9ULX5 | |
| NRRGLDMLTAAQGGI | 416 | P60508 | |
| AMQRIQGARVLVSGL | 26 | P41226 | |
| IQMTRRQSVGRGLQL | 2101 | P12270 | |
| LLGVTRDQRGNMGVS | 331 | Q9BRG2 | |
| RDQRGNMGVSSGLEL | 336 | Q9BRG2 | |
| LERNIRTMFIGGSQL | 346 | P80108 | |
| LGNQGQGRRELEMLS | 1486 | Q5T1R4 | |
| RGGCLMLQDTGISLL | 111 | Q8IV45 | |
| RLTRQVEALGLASGM | 76 | Q2TAL5 | |
| LRRMNQARLGLGTEG | 246 | A6NKC9 | |
| LVINLSMRGAGGRRL | 1391 | P27708 | |
| SLGLGGRSAIEQRSM | 686 | P11137 | |
| IRIRVVQMLGSLGGQ | 851 | P78527 | |
| GMLGRVNLGLSGVNI | 541 | Q96SK2 | |
| DTLAQMLTLGNIRAG | 186 | Q9UJA5 | |
| EQDMRSGVLGTRGRT | 281 | P56705 | |
| LGLGRIGREVATRMQ | 151 | O43175 | |
| SGQERGRLGVLAMSC | 301 | Q96QU8 | |
| QLGTTLDMGELRGLR | 181 | Q9H898 | |
| RNGTGTALRILSNGM | 246 | Q08ET2 | |
| EGGTDLRLAQRMSLG | 181 | Q14929 | |
| LERFGSLTMDGGLRN | 711 | Q9UHD2 | |
| TRMGGNTVIEGVNDR | 286 | Q9NQX4 | |
| VSSGGAGRLSMQELR | 6 | O14777 |